Targeting MGMT to treat therapy resistant and metastatic melanoma growth

Authors

Santhi Konduri, Advocate Aurora HealthFollow
Dmitry Bosenko, Advocate Aurora HealthFollow
Deborah Donohoe, Advocate Aurora HealthFollow
Maharaj Singh, Advocate Aurora HealthFollow
Richard Rovin, Advocate Aurora HealthFollow
George C. Bobustuc, Advocate Aurora HealthFollow

Recommended Citation

Konduri SD, Bosenko D, Donohoe DL, Singh M, Rovin RA, Bobustuc GC. Targeting MGMT to treat therapy resistant and metastatic melanoma growth. Poster presented at: Aurora Scientific Day; May 20, 2020; virtual webinar hosted in Milwaukee, WI.

Affiliations

Advocate Aurora Research Institute

Aurora Neurosciences Innovation Institute

Presentation Notes

Poster presented at: Aurora Scientific Day; May 20, 2020; virtual webinar hosted in Milwaukee, WI.

Document Type

Poster